NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical Company that develops and markets protein-based biosurgery and passive immunotherapy products, announced today that Robert Taub, President and CEO, is scheduled to give a Company presentation at the CIBC World Markets 18th Annual Healthcare Conference on Monday, November 5, 2007, at 4:15 p.m. ET, at the Waldorf=Astoria Hotel in New York City.
